185 related articles for article (PubMed ID: 10602441)
1. A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response.
Levy Y; Sherer Y; Ahmed A; Langevitz P; George J; Fabbrizzi F; Terryberry J; Meissner M; Lorber M; Peter JB; Shoenfeld Y
Lupus; 1999; 8(9):705-12. PubMed ID: 10602441
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
Perricone R; De Carolis C; Kröegler B; Greco E; Giacomelli R; Cipriani P; Fontana L; Perricone C
Rheumatology (Oxford); 2008 May; 47(5):646-51. PubMed ID: 18346976
[TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.
Toubi E; Kessel A; Shoenfeld Y
Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703
[TBL] [Abstract][Full Text] [Related]
4. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a single-center experience with 63 patients.
Nieto-Aristizábal I; Martínez T; Urbano MA; Posso-Osorio I; Plata IF; Garcia-Robledo JE; Aragón CC; Santos VA; Tobón GJ
Lupus; 2019 Nov; 28(13):1566-1570. PubMed ID: 31653191
[TBL] [Abstract][Full Text] [Related]
5. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus].
Francioni C; Fioravanti A; Gelli R; Megale F; Marcolongo R
Recenti Prog Med; 1993 Oct; 84(10):679-86. PubMed ID: 8235034
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin in the therapeutic armamentarium of systemic lupus erythematosus: a systematic review and meta-analysis.
Sakthiswary R; D'Cruz D
Medicine (Baltimore); 2014 Oct; 93(16):e86. PubMed ID: 25310743
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin therapy and systemic lupus erythematosus.
Zandman-Goddard G; Levy Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):219-28. PubMed ID: 16391397
[TBL] [Abstract][Full Text] [Related]
8. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre.
Camara I; Sciascia S; Simoes J; Pazzola G; Salas V; Karim Y; Roccatello D; Cuadrado MJ
Clin Exp Rheumatol; 2014; 32(1):41-7. PubMed ID: 24029366
[TBL] [Abstract][Full Text] [Related]
9. High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study.
Schroeder JO; Zeuner RA; Euler HH; Löffler H
J Rheumatol; 1996 Jan; 23(1):71-5. PubMed ID: 8838511
[TBL] [Abstract][Full Text] [Related]
10. Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin.
Levy Y; Sherer Y; George J; Langevitz P; Ahmed A; Bar-Dayan Y; Fabbrizzi F; Terryberry J; Peter J; Shoenfeld Y
Int Arch Allergy Immunol; 1999 Jul; 119(3):231-8. PubMed ID: 10436395
[TBL] [Abstract][Full Text] [Related]
11. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity.
Ippolito A; Wallace DJ; Gladman D; Fortin PR; Urowitz M; Werth V; Costner M; Gordon C; Alarcón GS; Ramsey-Goldman R; Maddison P; Clarke A; Bernatsky S; Manzi S; Bae SC; Merrill JT; Ginzler E; Hanly JG; Nived O; Sturfelt G; Sanchez-Guerrero J; Bruce I; Aranow C; Isenberg D; Zoma A; Magder LS; Buyon J; Kalunian K; Dooley MA; Steinsson K; van Vollenhoven RF; Stoll T; Weisman M; Petri M
Lupus; 2011 Mar; 20(3):250-5. PubMed ID: 21362750
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
[TBL] [Abstract][Full Text] [Related]
14. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
Chauhan SK; Rai R; Singh VV; Rai M; Rai G
Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
[TBL] [Abstract][Full Text] [Related]
15. [High dose intravenous immunoglobulins in treating systemic lupus erythematosus-associated thrombocytopenia].
Zhang X; Dong Y; Tang F; Zhang F; Li H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):82-4. PubMed ID: 12903501
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside.
Zandman-Goddard G; Blank M; Shoenfeld Y
Lupus; 2009 Sep; 18(10):884-8. PubMed ID: 19671787
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.
Sherer Y; Shoenfeld Y
Autoimmun Rev; 2006 Feb; 5(2):153-5. PubMed ID: 16431350
[TBL] [Abstract][Full Text] [Related]
18. Long-term therapy with intravenous immunoglobulin is beneficial in patients with autoimmune diseases.
Zandman-Goddard G; Krauthammer A; Levy Y; Langevitz P; Shoenfeld Y
Clin Rev Allergy Immunol; 2012 Apr; 42(2):247-55. PubMed ID: 21732045
[TBL] [Abstract][Full Text] [Related]
19. Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases.
Sherer Y; Kuechler S; Jose Scali J; Rovensky J; Levy Y; Zandman-Goddard G; Shoenfeld Y
Isr Med Assoc J; 2008 Jan; 10(1):55-7. PubMed ID: 18300575
[TBL] [Abstract][Full Text] [Related]
20. [Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab].
Tsanyan ME; Torgashina AV; Aleksandrova EN; Soloviev SK; Nasonov EL
Ter Arkh; 2013; 85(5):53-9. PubMed ID: 23819340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]